产品
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
Akeso launched a U.S. Phase II trial of its cadonilimab PD-1/CTLA-4 combination regimen for perioperative gastric cancer treatment.
大盘 打开原文 ↗